Production (Stage)
HCA Healthcare, Inc.
HCA
$376.59
-$0.05-0.01%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 18.32B | 18.29B | 17.49B | 17.49B | 17.34B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 18.32B | 18.29B | 17.49B | 17.49B | 17.34B |
| Cost of Revenue | 10.76B | 10.71B | 10.52B | 10.32B | 10.38B |
| Gross Profit | 7.56B | 7.58B | 6.97B | 7.17B | 6.96B |
| SG&A Expenses | -- | 1.05B | -- | -- | -- |
| Depreciation & Amortization | 860.00M | 856.00M | 842.00M | 819.00M | 795.00M |
| Other Operating Expenses | 3.85B | 2.82B | 3.72B | 3.62B | 3.61B |
| Total Operating Expenses | 15.47B | 15.44B | 15.08B | 14.76B | 14.78B |
| Operating Income | 2.86B | 2.85B | 2.41B | 2.73B | 2.56B |
| Income Before Tax | 2.33B | 2.13B | 1.91B | 2.24B | 2.25B |
| Income Tax Expenses | 502.00M | 447.00M | 424.00M | 550.00M | 445.00M |
| Earnings from Continuing Operations | 1.83B | 1.69B | 1.48B | 1.69B | 1.80B |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -215.00M | -248.00M | -212.00M | -226.00M | -211.00M |
| Net Income | 1.61B | 1.44B | 1.27B | 1.46B | 1.59B |
| EBIT | 2.86B | 2.85B | 2.41B | 2.73B | 2.56B |
| EBITDA | 3.72B | 3.70B | 3.25B | 3.55B | 3.36B |
| EPS Basic | 6.52 | 5.63 | 4.95 | 5.59 | 6.02 |
| Normalized Basic EPS | 5.02 | 4.73 | 3.82 | 4.46 | 4.04 |
| EPS Diluted | 6.45 | 5.63 | 4.88 | 5.53 | 5.93 |
| Normalized Diluted EPS | 4.97 | 4.73 | 3.78 | 4.41 | 3.98 |
| Average Basic Shares Outstanding | 246.94M | 255.31M | 256.76M | 261.16M | 264.44M |
| Average Diluted Shares Outstanding | 249.44M | 255.31M | 259.92M | 264.07M | 268.02M |
| Dividend Per Share | 0.72 | 0.66 | 0.66 | 0.66 | 0.66 |
| Payout Ratio | 11.18% | 11.47% | 13.31% | 11.70% | 11.63% |